Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $2.35 billion. The enterprise value is $10.70 billion.
| Market Cap | 2.35B |
| Enterprise Value | 10.70B |
Important Dates
The next estimated earnings date is Thursday, October 30, 2025, before market open.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
Organon & Co. has 259.97 million shares outstanding. The number of shares has increased by 1.06% in one year.
| Current Share Class | 259.97M |
| Shares Outstanding | 259.97M |
| Shares Change (YoY) | +1.06% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 0.37% |
| Owned by Institutions (%) | 82.42% |
| Float | 258.73M |
Valuation Ratios
The trailing PE ratio is 3.36 and the forward PE ratio is 2.38. Organon & Co.'s PEG ratio is 0.49.
| PE Ratio | 3.36 |
| Forward PE | 2.38 |
| PS Ratio | 0.38 |
| Forward PS | 0.38 |
| PB Ratio | 3.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.66 |
| P/OCF Ratio | 2.91 |
| PEG Ratio | 0.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.38, with an EV/FCF ratio of 16.27.
| EV / Earnings | 15.29 |
| EV / Sales | 1.70 |
| EV / EBITDA | 6.38 |
| EV / EBIT | 7.88 |
| EV / FCF | 16.27 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 12.14.
| Current Ratio | 1.65 |
| Quick Ratio | 0.75 |
| Debt / Equity | 12.14 |
| Debt / EBITDA | 5.11 |
| Debt / FCF | 13.52 |
| Interest Coverage | 2.65 |
Financial Efficiency
Return on equity (ROE) is 159.64% and return on invested capital (ROIC) is 9.21%.
| Return on Equity (ROE) | 159.64% |
| Return on Assets (ROA) | 6.62% |
| Return on Invested Capital (ROIC) | 9.21% |
| Return on Capital Employed (ROCE) | 12.69% |
| Revenue Per Employee | $628,100 |
| Profits Per Employee | $70,000 |
| Employee Count | 10,000 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.99 |
Taxes
| Income Tax | -34.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.27% in the last 52 weeks. The beta is 0.60, so Organon & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -48.27% |
| 50-Day Moving Average | 9.94 |
| 200-Day Moving Average | 11.63 |
| Relative Strength Index (RSI) | 30.32 |
| Average Volume (20 Days) | 3,196,035 |
Short Selling Information
The latest short interest is 12.82 million, so 4.93% of the outstanding shares have been sold short.
| Short Interest | 12.82M |
| Short Previous Month | 14.91M |
| Short % of Shares Out | 4.93% |
| Short % of Float | 4.95% |
| Short Ratio (days to cover) | 3.43 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.28 billion and earned $700.00 million in profits. Earnings per share was $2.69.
| Revenue | 6.28B |
| Gross Profit | 3.55B |
| Operating Income | 1.36B |
| Pretax Income | 666.00M |
| Net Income | 700.00M |
| EBITDA | 1.68B |
| EBIT | 1.36B |
| Earnings Per Share (EPS) | $2.69 |
Balance Sheet
The company has $599.00 million in cash and $8.90 billion in debt, giving a net cash position of -$8.30 billion or -$31.92 per share.
| Cash & Cash Equivalents | 599.00M |
| Total Debt | 8.90B |
| Net Cash | -8.30B |
| Net Cash Per Share | -$31.92 |
| Equity (Book Value) | 733.00M |
| Book Value Per Share | 2.82 |
| Working Capital | 1.82B |
Cash Flow
In the last 12 months, operating cash flow was $826.00 million and capital expenditures -$168.00 million, giving a free cash flow of $658.00 million.
| Operating Cash Flow | 826.00M |
| Capital Expenditures | -168.00M |
| Free Cash Flow | 658.00M |
| FCF Per Share | $2.53 |
Margins
Gross margin is 56.57%, with operating and profit margins of 21.62% and 11.14%.
| Gross Margin | 56.57% |
| Operating Margin | 21.62% |
| Pretax Margin | 10.60% |
| Profit Margin | 11.14% |
| EBITDA Margin | 26.70% |
| EBIT Margin | 21.62% |
| FCF Margin | 10.48% |
Dividends & Yields
This stock pays an annual dividend of $0.08, which amounts to a dividend yield of 0.89%.
| Dividend Per Share | $0.08 |
| Dividend Yield | 0.89% |
| Dividend Growth (YoY) | -46.43% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.32% |
| Buyback Yield | -1.06% |
| Shareholder Yield | -0.19% |
| Earnings Yield | 29.09% |
| FCF Yield | 27.35% |
Analyst Forecast
The average price target for Organon & Co. is $17.33, which is 91.81% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.33 |
| Price Target Difference | 91.81% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 0.59% |
| EPS Growth Forecast (5Y) | 4.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.27 |
| Piotroski F-Score | 5 |